Advertisement
Screener

REGEN BIOPHARMA, INC. (RGBP) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments

1.4 / 5 stars · 23/80 Roast Me

REGEN BIOPHARMA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments

REGEN BIOPHARMA, INC. (RGBP) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments of $0 for the 3-month period ending 2017-12-31, per its 10-Q filed 2018-02-06.

Discontinued › Notes › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments · last filed 2018-02-06

  • REGEN BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend payments for the quarter ending 2017-12-31 was $0.00.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments 3 month
2017-12-31$0.00
10-Q · filed 2018-02-06